Navigation Links
Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease
Date:4/15/2008

Effort utilizes Phreesia's automated patient check-in system to enable

better management of medication wear-off

NEW YORK, April 15 /PRNewswire/ -- Phreesia, Inc., the Patient Check-In Company, has announced that it will integrate a new screening tool developed by researchers at Duke University Medical Center into its electronic patient intake process, thereby potentially enhancing the ability of doctors to identify and manage the debilitating symptoms of Parkinson's disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/NYW106LOGO )

Affecting about one million people in the United States, Parkinson's disease is a degenerative disorder that impairs nerve cells causing patients to experience tremors, slowness of movement, muscle rigidity, and difficulty with balance. Drug therapy is highly effective, but within 2 years of initiating treatment up to 50% of patients can experience a decrease in drug efficacy, a phenomenon that is referred to as "wearing-off".

"Recognition of wearing-off and under treatment in Parkinson's disease patients is a major problem", said Mark Stacy, MD, Director of the Movement Disorders Center at Duke University's School of Medicine. Research has shown that nearly half of all patients that report wearing-off are not identified in a routine clinical exam. To help address this inconsistency, Phreesia will automate the "Wearing-Off Questionnaire-9" (WOQ-9), a highly sensitive screening tool specifically designed by researchers at Duke to identify these symptoms in the clinical setting.

Frequently, paper screening tools are cumbersome to implement clinically. As part of Phreesia's electronic patient intake system patients with Parkinson's disease will answer questions from the WOQ-9 and the results will be made available to their physician prior to starting the clinical exam. By enabling physicians nationwide to automate the WOQ-9 in their waiting room a higher identification rate of wearing-off is anticipated, ideally resulting in subsequent treatment and potentially better patient outcomes.

Physicians who use Phreesia will have the option to seamlessly integrate the WOQ-9 into their existing intake process and evaluate responses at both the patient and practice level. "This is Phreesia at its best -- leveraging evidence-based clinical assessment tools to improve patient care", said Chaim Indig, CEO of Phreesia. The implementation of the WOQ-9 is one of many clinical initiatives that Phreesia is developing for physicians who use their electronic patient check-in system.

About Phreesia:

Phreesia is the patient check-in company. Phreesia automates patient check-in and delivers fully interactive content direct-to-patients, designed to interface with physicians' existing and future technology. Replacing the outdated patient clipboard with a free wireless touch-screen and swipe-card enabled PhreesiaPad significantly improves the patient experience. Phreesia is committed to the ideals of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Phreesia is backed by premier venture capital firms and draws on the expertise of a leading Medical Advisory Board. http://www.phreesia.com


'/>"/>
SOURCE Phreesia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
2. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
3. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
4. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
5. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
6. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
7. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
8. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
9. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
10. Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
11. Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):